• Mashup Score: 4
    Real-world data and MRD in CLL - 4 year(s) ago

    Peter Hillmen, MBChB, FRCP, FRCPath, PhD, of the University of Leeds, Leeds, UK, evaluates the importance and challenges of real-world…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: Real world data #CLL w/ Peter Hillmen of @UniversityLeeds: https://t.co/Q2HQMmRBB5 @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #Leusm #Leukemia #RealWorldData

  • Mashup Score: 1
    DREAMM-3: belantamab mafodotin vs pom/dex for R/R myeloma - 4 year(s) ago

    Katja Weisel, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, discusses DREAMM-3, a Phase III, open-label, randomized study of single-agent belantamab…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: DREAMM-3: #Belantamab mafodotin vs pom/dex for R/R #Myeloma w/ Katja Weisel of @uni_tue: https://t.co/MY0koMT4Sa @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #MMsm #CTsm https://t.co/9QP6tpFZlT

  • Mashup Score: 0
    Assessing high-risk AML - 4 year(s) ago

    Nigel Russell, MD, of Guy’s Hospital NHS Trust, London, UK, explores how high-risk acute myeloid leukemia (AML) can be identified…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: Exploring the genomic profiling for assessing high risk #AML w/ Nigel Russel of @GSTTnhs: https://t.co/jv31x3epjN @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #Leukemia #Leusm

  • Mashup Score: 0
    COVID-19 and the NHS - 4 year(s) ago

    Wendy Osborne, MBBS (Hons), MRCP, FRCPath, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, discusses the impact…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: #COVID19 and the NHS: impacting care w/ Wendy Osborne of @NewcastleHosps: https://t.co/iixtW8CX7T @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert

  • Mashup Score: 2
    EHA 2020 CLL highlights: CLL14 & CAPTIVATE - 4 year(s) ago

    Paolo Ghia, MD, of the Università Vita-Salute San Raffaele, Milan, Italy, explores highlights from EHA 2020, including the CLL14 trial…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: EHA 2020 #CLL Highlights w/ Paolo Ghia of @MyUniSR : https://t.co/R7Cr3AwsIh @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #CLL #Leukemia #Leusm

  • Mashup Score: 4
    Onvansertib and decitabine in relapsed/refractory AML - 4 year(s) ago

    Amer Zeidan, MBBS, MHS, Yale University and Yale Cancer Center, New Haven, CT, discusses the updated analyses of a Phase…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: The effects of onvansertib and decitabine in relapsed and refractory #AML w/ @Dr_AmerZeidan of @YaleMed: https://t.co/Iypq7LGHE8 @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #Leusm #Leukemia #CTsm

  • Mashup Score: 0
    Facilitating iMCD diagnosis in the clinic - 4 year(s) ago

    Emmanuel Gyan, MD, PhD, University Hospital of Tours, Tours, France, discusses difficulties associated with idiopathic multicentric Castleman disease (iMCD) diagnosis…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: What difficulties arise in #iMCD diagnosis w/ Emmanuel Gyan: https://t.co/DFOihXnGxl @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #CastlemanDisease

Load More